The document discusses integrating tobacco control plans into national development plans and UN development assistance frameworks. It finds that while most countries have tobacco control strategies, few mention tobacco or the WHO FCTC in their national development plans or UNDAFs. Case studies found enabling factors include government leadership, civil society advocacy, and WHO/UNDP support. Challenges include lack of priority, resources, and data. It recommends continued advocacy, capacity building, learning from other health issues, focusing on taxation, protecting policy discussions, and monitoring integration efforts.
2nd Meeting of the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases Geneva, 30 January 2014. Dudley Tarlton.
2nd Meeting of the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases Geneva, 30 January 2014. Dudley Tarlton.
SCHEME OF PREVENTION OF ALCOHOLISM AND SUBSTANCE (DRUG) ABUSE, 2015GK Dutta
The approach of this Scheme is to provide the whole range of services including awareness generation, identification, counselling, treatment and rehabilitation of addicts through voluntary and other organizations. With a view to reducing the demand for and consumption of alcohol and dependence producing substances, the thrust would be on preventive education programmes and Whole Person Recovery of the drug dependent persons.
A presentation by Hemant Goswami on How tobacco industry have managed to manipulate the public health agenda over the years. Quoting from the tobacco industry documents itself, Hemant demonstrated the tactics the industry uses to plant tobacco control legislations themselves to prevent any effective and powerful legislation from coming into effect.
Example of how Indian Tobacco Control law has been weakened by the industry influence has also been given by Hemant in the presentation.
Standards and related issues in the WTO Agreement on SPS and TBTFAO
Ahmad Mukhtar
Economist -Trade and Food Security, FAO Liaison Office Geneva
Materials of the workshop on Resolving agricultural trade issues through the WTO organized by FAO in collaboration with Ukraine’s Ministry of Agrarian Policy and Food of Ukraine in Kyiv on June 7, 2017.
http://www.fao.org/economic/est/est-events-new/wtokiev/en/
http://www.fao.org/europe/news/detail-news/en/c/892730/
UNDP law reform and recommendations of UN High Level panel on Access to Medicines.
Presented by Judit Rius Sanjuan, UNDP HIV, Health and Development Group.
SCHEME OF PREVENTION OF ALCOHOLISM AND SUBSTANCE (DRUG) ABUSE, 2015GK Dutta
The approach of this Scheme is to provide the whole range of services including awareness generation, identification, counselling, treatment and rehabilitation of addicts through voluntary and other organizations. With a view to reducing the demand for and consumption of alcohol and dependence producing substances, the thrust would be on preventive education programmes and Whole Person Recovery of the drug dependent persons.
A presentation by Hemant Goswami on How tobacco industry have managed to manipulate the public health agenda over the years. Quoting from the tobacco industry documents itself, Hemant demonstrated the tactics the industry uses to plant tobacco control legislations themselves to prevent any effective and powerful legislation from coming into effect.
Example of how Indian Tobacco Control law has been weakened by the industry influence has also been given by Hemant in the presentation.
Standards and related issues in the WTO Agreement on SPS and TBTFAO
Ahmad Mukhtar
Economist -Trade and Food Security, FAO Liaison Office Geneva
Materials of the workshop on Resolving agricultural trade issues through the WTO organized by FAO in collaboration with Ukraine’s Ministry of Agrarian Policy and Food of Ukraine in Kyiv on June 7, 2017.
http://www.fao.org/economic/est/est-events-new/wtokiev/en/
http://www.fao.org/europe/news/detail-news/en/c/892730/
UNDP law reform and recommendations of UN High Level panel on Access to Medicines.
Presented by Judit Rius Sanjuan, UNDP HIV, Health and Development Group.
Presentation on the Access and Delivery Partnership by Tenu Avafia, 3 April 2014.
The presentation covered:
-Impact of NTDs, TB and Malaria on development outcomes;
-Dual challenges of Innovation and Access;
-Government of Japan and UNDP Partnership: Addressing innovation & Access
-Access and Delivery Partnership: strengthening capacity across the health system
According to a Lancet study (2012), in India, tobacco-related cancers represented 42·0% of male and 18·3% of female cancer deaths
India also has one of the highest rates of oral cancer in the world as the consequence of high prevalence of smokeless tobacco use
A presentation prepared for a UNDP webinar on "Addressing the Social Determinants of Noncommunicable Diseases". This presentation highlights the NCD crisis in the Pacific, discusses the determinants of NCDs in the Pacific (with an emphasis on trade), and discusses action and future work
Noncommunicable diseases (NCDs) - mainly cardiovascular disease, diabetes, cancer and chronic respiratory disease - are not just one of the world’s most pressing health concerns but also a significant development challenge. They impede social and economic development and are driven by underlying social, economic, political, environmental and cultural factors, broadly known as ‘social determinants’.
Working alongside specialist health partners, actors outside the health sector are uniquely well positioned to address the social determinants of NCDs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
1. Tobacco Control for Development
Integrating the WHO Framework
Convention on Tobacco Control into
national development plans and United
Nations Development Assistance
Frameworks (UNDAFs)
Douglas Webb, PhD, HIV, Health and Development Group
UN Development Programme, New York
Presented to the Governance of Tobacco in the 21st Century Conference,
University of Harvard/WHO February 2013
2. Mandate for UN system support
• FCTC COP decision FCTC/COP4/17
• ECOSOC resolution RES/2012/4
1. Encourages the Ad Hoc Inter-Agency Task Force to promote effective
tobacco control policies and assistance mechanisms at the national
level, including through the integration of the WHO FCTC implementation
efforts within the United Nations Development Assistance
Frameworks, where appropriate, in order to promote coordinated and
complementary work among funds, programmes and specialized agencies;
2. Invites all members of the Task Force and other United Nations funds,
programmes and specialized agencies to contribute, as appropriate, to the
goals of the Framework Convention, including through multisectoral
assistance, public outreach and communication, in particular in the context
of the prevention and control of non-communicable diseases;
3.
4.
5. Discussion paper; aims
• Articulate the case for the integration of tobacco
control plans into national development plans
and UN Development Assistance Frameworks
(UNDAFs)
• Assess current extent of integration of tobacco
control plans into national development plans
and UNDAFs
• Provide collated information about good practice
and recommendations for global and national
action from current experience
6. Sample countries
• 120 reported on 2012 reporting cycle
• Of these, 48 sample countries:
• 15 completed needs assessment
• CSO funding to integrate FCTC into
instruments (10)
• High tobacco use and burden (15)
• Countries that had made deliberate
integration efforts (8)
7. Article 5.1 Globally
Of the 120 of the 174 FCTC parties for whom data
is available from the 2012 reporting cycle:
• 74/120 (62%) indicated a comprehensive
multisectoral national tobacco control
strategy.
• 43 (36%) of parties reported tobacco control
being incorporated in national health plans and
• 21 (18%) parties reported including tobacco
control in other national plans.
8. NCDs mentioned in National Development
Plans n=28
NCDs
mentioned
(22)
NCDs not
mentioned (6)
9. Tobacco in National Development Plans n=28
no mention
tobacco
mentioned
(9)
NB – not one of the
sample countries
mentioned FCTC in NDP
10. Tobacco in UNDAFs n=46
F
FCTC
Specified (3)
Tobacco
Specified
(12)
Tobacco
not
mentioned
(29)
11. Desk Research Sample of 48 countries
• 28 NDPs reviewed
– 0 mentions of “FCTC”
– 8 include tobacco control measures
– 22 include NCDs
• 46 UNDAFs reviewed
– 3 include FCTC implementation
– + 1 inclusion of FCTC in list of treaty obligations
– 5 include tobacco control measures
12. Desk Research Sample of 48 countries
• 28 NDPs reviewed
– 0 mentions of “FCTC”
– 8 include tobacco control measures
– 22 include NCDs
• 46 UNDAFs reviewed
– 3 include FCTC implementation
– + 1 inclusion of FCTC in list of treaty obligations
– 5 include tobacco control measures
13. Case Studies
• 8 case study countries
• Interviews with
– Ministry of Health Tobacco Control Focal Points
– WHO Tobacco Control Focal Points
– UNDP relevant contacts
14. Emerging Lessons: Inclusion in NDPs
• FCTC should be a health priority championed
by Ministry of Health
• Policy advocacy should present:
– Evidence for relationship to poverty reduction
– Impact on other development priorities e.g.
reducing inequalities, improving access to
education
– Inter-relationships with existing health MDGs (and
emerging post 2015 development agenda)
15. Emerging Lessons: Inclusion in UNDAF
UNDAFs should support
• achieving NDP priorities – so FCTC should be
included in NDP
• delivery of international treaty obligations –
so FCTC should be listed
• coordination of UN agencies actions – so
UNCTs must be sensitised to relevance and
responsibilities
16. Emerging Lessons:
Multisectoral Approach
• Multisectoral tobacco control coordinating
committees facilitate integration into planning
processes
• Should include representation of other
ministries
(finance, justice, trade, agriculture, tourism
etc.)
• High level government leadership desirable
• Civil society representation desirable
17. Enabling Factors
• High level government leadership
• FCTC needs assessments and Secretariat support
• WHO technical support
• Civil society advocacy
• Accountability to the international
treaty, including reporting
• Top level UN recognition of need for support of
FCTC implementation
18. Challenges
• Lack of resources in Ministry of Health
• Lack of awareness of tobacco use as a health and
development issue
• Absence of tobacco control from development
partners’ priorities
• Lack of data on prevalence, morbidity, mortality
and costs
• Fears of economic impacts of tobacco control
• Tobacco industry influence
19. Recommendations
1. Support continued advocacy efforts at
national and international level
2. Provide capacity building to governments to
support the integration of FCTC into NDPs and
UNDAFs
3. Learn from experience of mainstreaming
HIV/AIDS
4. Focus on tobacco taxation as key entry point
20. Recommendations
5. Invest in data and analysis (especially the political
economy) of the epidemic and its impacts on other
development priorities
6. Support countries to develop cost estimates for
FCTC implementation
7. Protect multisectoral discussions of FCTC
implementation from tobacco control interference
(article 5.3).
8. Monitor situation as function of the Mechanisms
of Assistance WG of the COP
22. Potential UNDP roles
Some specific opportunities for UNDP in tobacco are
emerging
o UN system coordination (RC) and UNDAF integration
o Post-2015 development agenda
o Support to national NCD action plan development
o Integration of tobacco/FCTC/NCDs into national development
planning
o Support to national governance structures on tobacco/NCDs
o Anti-corruption and regulatory independence
o Intellectual property/TRIPS, trade
o Strengthening law enforcement, justice
o Strengthening local government-municipal programming
o CSO engagement
o Gender and tobacco, human rights
23. Thank you
Douglas Webb, Ph.D.
HIV, Health and Development Practice
Bureau for Development Policy
UNDP New York
Email: douglas.webb@undp.org
Acknowledgements to Alison Cox, Brian Lutz and
Michelle Sahal-Estime
Editor's Notes
FACT:Expected to cause 6.4million deaths by 2015 – i.e. 10% of all deathsBy 2030 the number of smoking related deaths in LMICs alone is expected to rise to 6.8 million
In 2011 55% of the world’s population was covered by just one of the FCTC key interventions, and less than 17% by more than two. (NB figures from MPOWER report not FCTC implementation reports)
FACTL Just 4 countries were found to include tobacco control in their NDP and support for FCTC implementation or tobacco control measures in their UNDAF (including the one that just lists FCTC amongst its treaty obligations)
FACTL Just 4 countries were found to include tobacco control in their NDP and support for FCTC implementation or tobacco control measures in their UNDAF (including the one that just lists FCTC amongst its treaty obligations)
Bolivia, The Gambia, Ghana, Jordan, Mauritania, Moldova, Niger, Palau, The Solomon Islands